BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 10474759)

  • 21. Health-related quality of life and symptom management research sponsored by the National Cancer Institute.
    Minasian LM; O'Mara AM; Reeve BB; Denicoff AM; Kelaghan J; Rowland JH; Trimble EL;
    J Clin Oncol; 2007 Nov; 25(32):5128-32. PubMed ID: 17991932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Research-design issues in cancer-symptom-management trials using complementary and alternative medicine: lessons from the National Cancer Institute Community Clinical Oncology Program experience.
    Buchanan DR; White JD; O'Mara AM; Kelaghan JW; Smith WB; Minasian LM
    J Clin Oncol; 2005 Sep; 23(27):6682-9. PubMed ID: 16170176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes and metrics: measuring the impact of a comprehensive adolescent and young adult cancer program.
    Greenberg M; Klassen A; Gafni A; McBride ML; Albritton K
    Cancer; 2011 May; 117(10 Suppl):2342-50. PubMed ID: 21523756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The NCIC-Manitoba Breast Tumor Bank: a resource for applied cancer research.
    Watson PH; Snell L; Parisien M
    CMAJ; 1996 Aug; 155(3):281-3. PubMed ID: 8705906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New standards and implications for improving the quality of supportive oncology practice.
    Ferrell B; Paice J; Koczywas M
    J Clin Oncol; 2008 Aug; 26(23):3824-31. PubMed ID: 18688048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dispelling myths about palliative care and older adults.
    Duggleby W; Raudonis BM
    Semin Oncol Nurs; 2006 Feb; 22(1):58-64. PubMed ID: 16458184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluating health-related quality of life in cancer clinical trials: the National Cancer Institute of Canada Clinical Trials Group experience.
    Osoba D; Bezjak A; Brundage M; Pater J;
    Value Health; 2007; 10 Suppl 2():S138-45. PubMed ID: 17995472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enrollment of older patients in cancer treatment trials in Canada: why is age a barrier?
    Yee KW; Pater JL; Pho L; Zee B; Siu LL
    J Clin Oncol; 2003 Apr; 21(8):1618-23. PubMed ID: 12697888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Closing the divide: diverse populations and cancer survivorship.
    Guidry JJ; Torrence W; Herbelin S
    Cancer; 2005 Dec; 104(11 Suppl):2577-83. PubMed ID: 16258930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In pursuit of excellence for patients with cancer: the Scottish Cancer Therapy Network model.
    Stroner PL; Brewster DH; Dewar JA; Eremin O; Gould A; Howard GC; Kaye SB
    Br J Cancer; 1999 Apr; 79(11-12):1641-5. PubMed ID: 10206271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Attitudes of medical oncologists toward palliative care for patients with advanced and incurable cancer: report on a survery by the European Society of Medical Oncology Taskforce on Palliative and Supportive Care.
    Cherny NI; Catane R;
    Cancer; 2003 Dec; 98(11):2502-10. PubMed ID: 14635087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.
    Edwards BK; Brown ML; Wingo PA; Howe HL; Ward E; Ries LA; Schrag D; Jamison PM; Jemal A; Wu XC; Friedman C; Harlan L; Warren J; Anderson RN; Pickle LW
    J Natl Cancer Inst; 2005 Oct; 97(19):1407-27. PubMed ID: 16204691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The surgeon and palliative care.
    Podnos YD; Wagman LD
    Ann Surg Oncol; 2007 Apr; 14(4):1257-63. PubMed ID: 17096051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parents' perspective on symptoms, quality of life, characteristics of death and end-of-life decisions for children dying from cancer.
    Hechler T; Blankenburg M; Friedrichsdorf SJ; Garske D; Hübner B; Menke A; Wamsler C; Wolfe J; Zernikow B
    Klin Padiatr; 2008; 220(3):166-74. PubMed ID: 18478489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. American Society of Clinical Oncology guidance statement: the cost of cancer care.
    Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
    J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opportunities and challenges in the prevention and control of cancer and other chronic diseases: children's diet and nutrition and weight and physical activity.
    Tercyak KP; Tyc VL
    J Pediatr Psychol; 2006 Sep; 31(8):750-63. PubMed ID: 16820383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Developing a managed clinical network in palliative care: a realistic evaluation.
    Tolson D; McIntosh J; Loftus L; Cormie P
    Int J Nurs Stud; 2007 Feb; 44(2):183-95. PubMed ID: 16423354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Special Populations Networks for cancer awareness research and training.
    Chu KC; Jackson FE
    Pac Health Dialog; 2004 Sep; 11(2):222-4. PubMed ID: 16281704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.